Search Results 81-90 of 17038 for monoclonal antibody

1. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

   Penpulimab-kcqx is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

2. Anti-interleukin-5 therapy for severe asthma: A new therapeutic option - Mayo Clinic

   Further research is underway to identify other potential targets for asthma monoclonal antibody therapy. For more information. Benralizumab (Fasenra) for ...

3. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

4. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   GA101 is an anti-CD20 humanized and glyco-engineered monoclonal antibody. GA101 has been shown to have increased antibody-dependent cellular cytotoxicity ...

5. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Prior anti-cancer monoclonal antibody (mAb) =< 4 weeks prior to registration ...

6. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

7. Mayo Clinic research finds immune system responds to mRNA treatment for cancer

   Dong and his team produced an immune system protein in the lab ― a monoclonal antibody ― that can detect the protein levels in tumor tissues. The goal was ...

8. Trastuzumab (intravenous route) - Side effects & uses - Mayo Clinic

   Trastuzumab is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal ...

9. Multiple myeloma - Symptoms and causes - Mayo Clinic

   The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...

10. Mayo Clinic Q&A - Dr. Yi LIn - Multiple myeloma

    We also have since then monoclonal antibody treatments. So, these are again drugs that can be given IV that target certain markers that can show up on plasma ...